LEP Biomedical
Company

LEP Biomedical

Biotechnology Research Naas, Kildare, Ie 3 employees
Employees
3
Contacts
1
Emails
1

LEP Biomedical Overview

Headquarters
Naas, Kildare, Ie
Industry
Biotechnology Research
Employees
3
Founded
2023
Funding
5,679
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About LEP Biomedical

LEP Biomedical's core mission is to make glaucoma drainage surgeries 100% successful and relieve the burden associated with post-surgery follow up care. LEP Biomedical specializes in local ophthalmic drug delivery. Specifically,"HyaGuard" is our biodegradable solution designed to replace patient-administered anti-inflammatory drops. HyaGuard is also designed to be compatible with traditional trabeculectomy surgeries or drainage tubes. HyaGuard is rapidly and easily inserted into the sub-conjunctival space at the end of a standard surgery. Here, it delivers anti-inflammatory drugs in a controlled manner. This is intended to eliminate the need for self-administered anti-inflammatory drops, decrease post-surgical complications and improve patient quality of life.

LEP Biomedical Contact Details

People in AeroLeads
3
With contact data
1
Email contacts
1
33.3% coverage

LEP Biomedical Org Chart

Sample employees and titles
Name Title Contact
Ronan Mac Loughlin Phd Mbs Respiratory Drug Delivery
Email
Alan Hibbitts Founder & CEO: Lep Biomedical Ltd
View
Dr Colm O'brien Glaucoma Specialist Medical Doctor
View

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile

Compare Similar Companies to LEP Biomedical